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Abstract: Nucleolytic enzymes are associated with various diseases, and several methods 
have been developed for their detection. DNase expression is modulated in such diseases  
as acute myocardial infarction, transient myocardial ischemia, oral cancer, stomach cancer, 
and malignant lymphoma, and DNase I is used in cystic fibroma therapy. RNase is  
used to treat mesothelial cancer because of its antiproliferative, cytotoxic, and antineoplastic 
activities. Angiogenin, an angiogenic factor, is a member of the RNase A family. 
Angiogenin inhibitors are being developed as anticancer drugs. In this review, we describe  
fluorometric and electrochemical techniques for detecting DNase and RNase in disease. 
Oligonucleotides having fluorescence resonance energy transfer (FRET)-causing 
chromophores are non-fluorescent by themselves, yet become fluorescent upon cleavage 
by DNase or RNase. These oligonucleotides serve as a powerful tool to detect activities of 
these enzymes and provide a basis for drug discovery. In electrochemical techniques, 
ferrocenyl oligonucleotides with or without a ribonucleoside unit are used for the detection 
of RNase or DNase. This technique has been used to monitor blood or serum samples in 
several diseases associated with DNase and RNase and is unaffected by interferents in 
these sample types. 
Keywords: nuclease; DNase I; RNase A; oligonucleotide; disease marker; 
electrochemistry; fluorescence resonance energy transfer (FRET); nanocluster 
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1. Introduction 
Nucleases cleave or digest the phosphodiester bonds of DNA [1], RNA [2], and/or DNA-RNA 
hybrids [3]. They prevent replication errors and eliminate fragmentation of RNA or DNA, which may 
induce programmed cell death [1–3]. Nucleases prevent invasion or infection by viruses carrying 
single- or double-stranded nucleic acids, and they are expressed in the saliva, sudoriferous glands, and 
skin [1–3]. These enzymes are called deoxyribonuclease (DNase) or ribonuclease (RNase) for their 
respective substrates [1,2,4]. In the laboratory, DNase I is required to remove DNA from samples used 
in mRNA expression assays, whereas RNase A is used to remove RNA from samples used for DNA 
analysis. DNase and RNase are important for modifying and metabolizing nucleic acid chains and can 
be used as disease markers [4–13]. We provide a summary review of the detection methods for DNase 
and RNase as disease markers (Table 1). 
Table 1. Analytical performance of DNase and RNase detection platforms. 
No. Sensing Platform Target Detection Limit Linear Range [Reference] 
1 Single radial enzyme diffusion method DNase I 15.6 ng/mL 15.6–500 mg/mL [8] 
2 Fluorometric detection with dsDNA coupled with picogreen DNase I 5 pg 1–100 pg [14] 
3 DNaseAlert® DNase I 0.005 unit 0.005–0.5 unit [15] 
4 FRET dsDNA probe 
DNase I 
Exonuclease 
40 unit/L 
2.0 unit/L 
40–500 unit/L 
2.0–400 unit/L 
[16] 
5 Fe3O4
@MIP nanoparticle DNase I - - [17] 
6 
Immunochemical detection using 794 bp PCR product 
labeled fluorescein and biotin 
DNase II 0.05 unit/mL 0.025–4 unit/mL [18] 
7 Graphene-based fluorescence assay DNase I 1.75 unit/mL 1.75–70 unit/mL [19] 
8 
Electrochemical detection based single stranded break in 
homogeneous solution 
DNase I 0.6 ng/mL 0.6–1000 ng/mL [20] 
9 
Electrochemical detection based single stranded break with 
DNA modified electrode 
DNase I 0.2 ng/mL - [21] 
10 
Electrochemical detection using FcODN in homogeneous 
solution 
S1 nuclease 0.25 unit/μL - [22] 
11 
Electrochemical detection using FcODN modified electrode 
(Au-S linkage) 
DNase I 10−4 unit/μL 10−4–10−2 unit/μL [23] 
12 
Electrochemical detection using FcODN modified electrode 
(cytosine oligonucleotide) 
DNase I 10−5 unit/μL 10−5–10−3 unit/μL [24] 
13 
Potentiometric sensing using polycation sensitive membrane 
electrode 
S1 nuclease 
DNase I 
0.32 unit/mL 
0.45 unit/mL 
- 
1–10 unit/mL 
[25] 
14 ds DNA template formation Cu nanoparticle S1 nuclease 0.3 unit/mL 1–50 unit/mL [26] 
15 DNA template gold/silver nanocluster DNase II 3 ng/mL 0.013–60 μg/mL [27] 
16 positively charged QDs-based FRET probe MNase 1.6 unit/L 8–90 unit/L [28] 
17 RNaseAlert® RNase A 0.25 pg 0.25–2.0 pg [15] 
18 FRET dsDNA-RNA probe RNase H 28 pM 30–120 pM [29] 
19 Electrochemical detection using mRNA modified electrode RNase A 0.2 pg 0.2–10 pg [30] 
20 
Electrochemical detection using FcODN modified electrode 
(cytosine oligonucleotide) 
RNase A 10 pg/mL 1 pg/mL–1 μg/mL [31] 
21 RNA modified magnetic nanoparticle RNase A 
10−8 unit 
(4 pg/mL) 
9.2 × 10−9–9.2 × 10−4 
unit 
[32] 
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2. Characteristics of Nucleases 
2.1. Characteristics of DNase 
DNase I is a typical DNase that cleaves the 3'-phosphate from single- or double-stranded DNA in 
the presence of Mg
2+
 to generate 5'-phosphate and 3'-hydroxy termini [1]. DNase I cleaves single- and 
double-stranded DNA with some preference for 5'-pyridimidine purine-pyrimidine sequences. In 1957, 
DNase I was recognized as a useful marker of Staphylococcus infection in human and animal skin [4]. 
Staphylococcus aureus is ubiquitous and is associated with food poisoning, pneumonia, and blood 
poisoning. Detection of S. aureus is important, but distinguishing this pathogen from the common 
nontoxic, coagulase-negative staphylococci is difficult. DNase produced by S. aureus may be a useful 
marker for this pathogen. For detection, sample bacteria are cultured on selective media containing 
DNA; the presence of S. aureus is indicated by the absence of white turbidity upon addition of 
hydrochloride. S. aureus cultured on agar containing DNA and toluidine blue turns the medium 
burgundy. These behaviors are associated with DNase activity. 
DNase can also be used as a marker of disease. For instance, accumulation of DNA or DNA-protein 
complexes in the blood causes several autoimmune diseases [5,6]. This accumulation on blood vessel 
walls, glomeruli, or joints leads to glomerular nephritis, arthritis, or anthema [7]. Individuals with these 
diseases have been found to express lower levels of DNase I than do normal individuals. In contrast, 
DNase I activity in blood is higher in patients with breast or oral cancer and lower in patients with 
lymphatic malignancies or stomach cancer [8]. Increased DNase I activity is a marker of acute 
myocardial infarction and transient myocardial ischemia. Transarterial chemoembolization is an 
effective cure for liver cancer, but survival rates are low in patients with blood DNase activity below 
21% within 24 h after treatment [9]. DNase is used to monitor treatment response and is used to treat 
cystic fibroma (CF), in which patients accumulate DNA in the blood. DNase I treatment promotes 
DNA metabolism [10]. 
2.2. Characteristic of RNase 
RNase A is a typical RNase (13,686 Da; 124 amino acids) and was the third protein to be defined 
by X-ray structure analysis [33,34]; it was chemically synthesized by Merrifield [35], who demonstrated 
its biological and chemical synthesis. RNase A is an endonuclease that cleaves single-stranded RNA at 
cytosine (C) or uracil (U) residues, producing 3'-phosphate termini. RNase A has antiproliferative, 
cytotoxic, and tumor-inhibiting activities and the homologous ranpirnase (ONCONASE
TM
) has been 
developed as an antineoplastic drug for mesothelial and cutaneous cancers [11,12,36]. In contrast, the 
RNase angiogenin mediates vascularization to repair damaged blood vessels and during cancer 
development [37]. Since angiogenin inhibitors block vascularization, it is a candidate anti-cancer drug. 
Thus, RNase A is an important target for drug discovery. RNase is also a candidate disease marker for 
ovarian tumors and thyroid and pancreatic cancer [4,5]. 
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3. Detection of DNase 
3.1. Fluorometric DNase Detection 
Fluorometric nuclease detecting methods are summarized in Figure 1. DNase I generates short DNA 
fragments by cleavage. Thus, DNase I can be detected as DNA fragmentation on gel electrophoresis. 
DNase I activity can also be monitored spectrophotometrically, due to the hyperchromic effect of the 
absorption region based on nucleotide bases [38]. PicoGreen fluoresces upon binding to double-stranded 
DNA and is used for fluorometric monitoring of short DNA fragments generated by DNase I  
(Figure 1A) [13]. Single radial enzyme diffusion (SRED) has also been developed for detection of 
DNase activity [8]. SRED is performed in agarose gel containing DNA and ethidium bromide (EtBr). 
Samples are spotted on the agarose gel; shortened EtBr-stained DNA fragments diffuse in the gel with 
DNase activity, and emit light. DNase I activity is estimated from the light-emitting area. Mammalian 
DNase I was classified by SRED into three types: pancreas, parotid, and their mixture [14]. 
Figure 1. Fluorometric nuclease detection methods: (A) fluorescence intensity of non-covalent 
DNA-binding ligand; (B) recovery of self-quenched covalent fluorescent dye-DNA conjugate; 
(C) dequenching of FRET probes; (D) dequenching of hairpin-type FRET probes partially 
modified by phosphorothioate; and (E) de-hybridization of duplexes carrying FRET dyes 
after digestion with DNase, RNase, Exonuclease 1, or RNase H.  
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DNase I detection sensitivity was improved by using a fluorescent dye-DNA covalent conjugate 
(Figure 1B) [39]. Fluorescence of this covalent conjugate was quenched and its fluorescent was 
recovered by degradation or digestion with DNase I. This method can detect picogram amounts  
of DNase I. 
DNase I antibodies have been developed and used for enzyme-linked immunosorbent assay 
detection [40]. This is a convenient and sensitive method for measuring DNase content, though it does 
not necessarily reflect DNase activity. 
Sophisticated methods have been developed for fluorescence resonance energy transfer (FRET) 
with oligonucleotides carrying a fluorophore and a quencher (Figure 1C) [15]. Fluorescence is quenched 
until DNase is added; then, the oligonucleotide is cleaved, releasing the chromophores; fluorescence 
intensity thus represents DNase activity. The oligonucleotides to be used are commercially available as 
DNaseAlert
TM
 [15]. The detection limit of this probe is 5 × 10
−3
 U or 10 pg after 30 min at 37 °C and 
is thus rapid and highly sensitive. The FRET probe was also improved by the introduction of hairpin 
DNA sequences and partial displacement of phosphate with phosphorothioate (Figure 1D) [16]. These 
types of probes withstand the cellular environments, and sensitive detection of DNase I was realized 
with detection limit of 40 U/L. This probe was modified for Exonuclease I monitoring and provides 
intracellular fluorescence imaging. Simultaneous fluorescence imaging of DNase I and Endonuclease I 
activities was achieved by using two fluorophores (Figure 1). 
Body fluids contain interferents that disrupt fluorescence detection. To remove them, DNase  
I-cleaved oligonucleotide fragments are purified before fluorescence detection [17]. Alternatively, 
DNase I is detected by using biotin- and fluorescein-modified PCR products immobilized on 
streptavidin-coated plates [18].
 
Real-time fluorescence detection has been developed with graphene oxide (GO) and  
fluorescence-modified oligonucleotides (Figure 2) [19]. Dye fluorescence is quenched by adsorption 
on GO and is restored by desorption. When fluorescence-modified double-stranded oligonucleotides 
were mixed with GO, the oligonucleotide was spontaneously adsorbed and its fluorescence was 
quenched. DNase I digestion released the labeled oligonucleotides to fluoresce. The detection limit of 
this method is 1.75 U/mL in real time. 
Figure 2. DNase I detection based on dequenching of fluorescence dye-labeled DNA 
duplexes on a GO surface. 
 
3.2. Electrochemical DNase Detection 
Electrochemical nuclease detection methods are summarized in Figure 3. These methods are fast, 
easy to run, and require only compact instrumentation, thus allowing on-site diagnostics with a 
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powerful detection tool. Electrochemical techniques are not affected by sample impurities. Nucleic 
bases undergo an electrochemical redox reaction and the reduction peak at −1.4 V as a reference for 
potential of standard calomel electrode (SCE) (vs. SCE) was observed for damaged DNA carrying 
exposed nucleic bases under adsorptive transfer stripping alternating voltammetry (AdTS AC 
voltammetry) [20,21]. Fojta and co-workers detected DNAse I by immobilizing plasmid DNA on an 
electrode (Figure 3A) [41]. Electrochemical nuclease detection with ferrocene oligonucleotide has 
been reported in homogenous solution (Figure 3B) [22]. Ferrocene is an electrochemically active 
signaling molecule that was immobilized with oligonucleotide to produce FcODN. In general, the 
observed current depends on the diffusion rate of the electrochemically active material; a larger  
current intensity is obtained with a smaller diffusion constant. Nuclease treatment with FcODN 
increased current intensity based on the ferrocene moiety with decreasing molecular weight as 
digestion progressed. Under differential pulse voltammetry, S1 nuclease, which is an endonuclease that 
degrades single-stranded regions of duplex DNA, was detected as an increasing peak current at  
0.14 V vs. Ag/AgCl with the detection limit of 0.25 U/μL [23]. 
Figure 3. Electrochemical nuclease detection based on (A) direct redox of nucleobases 
exposed by nuclease digestion; (B) diffusion of ferrocene after fragmentation by nuclease; 
(C) loss of the ferrocene moiety from the electrode by digestion of the nuclease substrate; 
and (D) direct detection of nucleobases after nuclease digestion and hydrolysis. 
 
DNase can be detected by FcODN-immobilized electrodes, which provide real-time monitoring 
(Figure 3C). FcODN is immobilized on the electrode by Au-S linkages [23] (Figure 4A) or by reaction 
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of cytosine moieties with amino moieties on the electrode surface (Figure 4B) [24]. DNase I addition 
causes cleavage of the ferrocene-oligonucleotide fragment and release from the electrode. Thus,  
the decrease in ferrocene causes a drop in the current, thus reflecting DNase I activity. DNase I  
was detected by a decrease in peak current at 0.18 V vs. Ag/AgCl under Osteryoung square wave 
voltammetry with a detection limit of 1 × 10
−4
 U/μL with an Au-S electrode or 1 × 10−5 U/μL with a 
cytosine-amino moiety linkage. These differences are derived from the orientation of the oligonucleotide 
on the electrode. Enzyme reactivity on a substrate-immobilized surface is depends on the orientation, 
mobility, and density of substrate on the electrode. DNase activity in blood may serve as a marker for 
breast cancer, oral cancer, or acute myocardial infarction. It is measured using an FcODN-immobilized 
electrode in the absence or presence of EDTA [23]. The presence of DNase I is indicated by a decrease 
in current in the presence of EDTA, which inactivates the enzyme. The accuracy of fluorometric  
and optical DNase I detection is limited by the turbidity of the blood sample; in contrast, the 
electrochemical technique is unaffected by sample turbidity.  
Figure 4. Nuclease detection by a ferrocene-modified oligonucleotide immobilized to an 
electrode through an Au-S linkage (a) and reaction of a cytosine oligonucleotide with 
activated ester-immobilized electrode (b). Current intensities at both electrodes decrease 
upon digestion with DNase I. 
 
DNase I can be detected by complexing DNA with a polycationic polymer (Figure 5). DNA is a 
polyanionic polymer that complexes with polycationic polymers, thus neutralizing its charge; however, 
digestion with DNase I destabilizes the polymer complex and misbalances the charge, generating an 
electromotive force that can be detected electrochemically. In one example of this technique, DNase I 
and S1 nuclease were detected at 4.5 × 10
−4
 U/µL and 3.2 × 10
−4
 U/µL, respectively, with protamine as 
a polycationic polymer and a polycation-sensitive membrane electrode [25]. 
Fluorometric S1 nuclease detection was also achieved by detecting fluorescent copper nanoparticles 
formed in the presence of a double-stranded DNA template [26]. S1 nuclease was detected from a 
decrease in the fluorescence at 560 nm with a detection limit of 0.3 U/mL. Both methods can detect 
DNase I or S1 nuclease with high sensitivity in homogeneous solution. 
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Figure 5. Nuclease detection with a polycation-sensitive membrane electrode based on the 
electromotive force (EMF) difference in the complexed polycationic polymer and DNA 
before and after digestion with DNase I. 
 
DNase I can be detected with fluorescent DNA-template gold/silver nanoclusters (DNA-Au/Ag 
NCs) (Figure 6A) [42]. When gold/silver nanoclusters were prepared in the presence of DNA template, 
fluorescence emission varied with size, which was influenced by the length of the DNA. When DNase I 
was treated with gold/silver nanoclusters, DNA was digested and the nanoclusters formed aggregates. 
DNase I was detected in saliva and serum samples and showed a linear correlation from 13 ng/mL  
to 60 µg/mL with a detection limit of 3 ng/mL. Quantitative detection of micrococcal nuclease 
(MNase) has been performed by electrostatic interaction-based fluorescence resonance energy transfer 
(FRET) between positively charged QDs and negatively charged dye-labeled single-stranded DNA 
(Figure 6B) [27]. This technique detects MNase concentrations over a range of 8 × 10
−3
 to  
9.0 × 10
−2
 unit·mL
−1
, with a limit of detection of 1.6 × 10
−3
 unit·mL
−1
. 
Figure 6. (A) DNase I detection of aggregated fluorescent DNA-covered nanoparticles 
after digestion with DNase I; (B) DNase I detection by electrostatic interaction-based FRET 
between positively charged QDs and negatively charged dye-labeled single-stranded DNA. 
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4. RNase Detection 
4.1. Fluorometric RNase Detection 
RNase A is an endonuclease analogous to DNase I. Uridine 3'-(p-nitrophenylphosphate) or uridine 
3'-nitorophenylphosphate-(5-bromo-4-chloroindol-3-yl)-phosphate has been used for spectrophotometric 
detection of RNase [28]. However, RNase A has low kcat/Km values for these substrates. Rains and  
co-workers [29] identified AUAA or ACAA as a good substrate sequence for RNase A. A FRET probe 
labeled with two chromophores (6-FAM-dArUdAdA-6-TAMRA) was synthesized to detect RNase A 
activity (Figure 7A,B). FAM fluorescence was quenched by TAMRA and increased 180-fold after 
cleavage of the ribouridine (rU) site by RNase. This probe exhibited a kcat/Km of 3.6 × 10
7
 M
−1
·s
−1
,  
10-fold greater than previous reports. Angiogenin, an RNase A associated with cancer, exhibited a 
kcat/Km of 3.3 × 10
7
 M
−1
·s
−1
, similar to the value for RNase A. This probe was used in an inhibition 
assay with 3'-UMP and 5'-ADP [29]. Digestion of 0.6 μM fluorescence probe with 0.57 pM RNase A 
was performed in the presence of 3'-UMP and 5'-ADP, yielding inhibition constants, Kis, of 60 μM and 
8.4 μM for 3'-UMP and 5'-ADP, respectively. Thus, the probe can be used to detect RNase activity and 
as a screening reagent for angiogenin. Another type of fluorescence probe is composed of a duplex 
between a fluorescein-modified RNA strand and a dabcyl-DNA strand [30]. Although fluorescence is 
quenched by dabcyl through FRET, it is recovered after treatment with RNase H, which cleaves the 
RNA strand in the DNA-RNA hybrid (Figure 7C). FRET probes containing ribonucleotides make it 
possible to monitor RNase H, even in the cell. 
Figure 7. (A) Chemical structure of the FRET probe for RNase A detection; (B) RNase A 
and (C) RNase H detection with FRET probes. 
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4.2. Electrochemical RNase Detection 
Electrochemical methods, such as those involving ferrocenyl naphthalene diimide (FND) coupled to 
an mRNA-bound electrode, are used to detect RNase (Figure 8) [43]. FND has been developed as an 
electrochemical DNA duplex indicator [31,44], but FND also bound to mRNA with relatively low 
affinity, which could be due to the higher order structures containing double stranded regions within 
the mRNA. FND can be absorbed into mRNA-immobilized electrode, which allows FND concentration 
on the mRNA-immobilized electrode (Figure 8a). When the electrode was treated with RNase A, the 
amount of mRNA on the electrode decreased. RNase A activity is represented by the decreasing 
current with a linear range of 0.2–10 ng/mL and a detection limit of 0.2 pg. RNase A detection was 
performed by electrode-immobilized FcODN containing dArCdAdA and continuous cytosines (Cs) 
(Figure 8b) [32]. This FcODN was immobilized on the electrode through reaction of its continuous  
Cs with activated ester moieties coating the electrode surface. When the rC of FcODN on the  
electrode was cleaved by RNase A, FcODN fragments containing ferrocene were released, reducing 
the current, which is detected as RNase A activity. This electrode provides quantitative detection of 
RNase A from 1 × 10
−11
 g/mL to 1 × 10
−6
 g/mL by Osteryoung square wave voltammetry. Guanidine 
thiocyanate and EDTA inhibit the activity of RNaseA and DNase I, respectively; the specificity of the  
FcODN-immobilized electrode for these enzymes is derived from these properties.  
Figure 8. RNase detection with mRNA immobilized on a glassy carbon electrode (a) or 
ferrocene oligonucleotide with a ribonucleoside unit immobilized via continuous cytosine 
and the activated ester electrode (b). Current intensities decrease with RNase A activity. 
 
Wang’s group described a sensitive method for detection of RNase A by using substrate 
oligonucleotides immobilized on magnetic beads. After digestion with RNase A and acid dipurinization, 
the guanine bases were separated from the magnetic beads and detected by stripping chronopotentiometric 
measurements with a graphite pencil electrode (Figure 9). RNase A activity is estimated by the current 
peak at 0.8 V vs. Ag/AgCl from the guanine base. The authors were thus able to detect 4 × 10
−12
 g/mL 
RNase A using the lowest potential based on a guanine base [45]. 
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Figure 9. RNase digestion and dipurinization is followed by stripping chronopotentiometric 
measurements with a graphite pencil electrode to produce a guanine redox peak. 
 
5. Conclusions 
DNase and RNase can be detected by fluorometric and electrochemical techniques with several 
kinds of synthetic oligonucleotide substrates. Drug discovery will be facilitated by high-throughput 
screening of DNase and RNase drugs with a fluorometric technique in a microtiter format; in addition, 
electrochemical techniques are useful for detecting enzymes associated with disease. These techniques 
are especially good at producing data even in the presence of interfering substances. Table 2 shows the 
latest reports of DNase and RNase detection; nanoparticles were used in No. 2, 5, and 6 in Table 2. 
Finally, the development of improved nuclease probes will help clarify the function of DNase and 
RNase and the mechanism of their involvement in disease. 
Table 2. Analytical performance in platforms of DNase and RNase detection (2012–2013). 
No. Sensing Platform Target 
Detection 
Limit 
Linear Range 
[Reference] 
(year) 
1 FRET dsDNA probe 
DNase I 
Exonuclease 
40 unit/L 
2.0 unit/L 
40–500 unit/L 
2.0–400 unit/L 
[16] 
(2013) 
2 Fe3O4@MIP nanoparticle DNase I - - 
[17] 
(2013) 
3 Graphene-based fluorescence assay DNase I 1.75 unit/mL 1.75–70 unit/mL 
[19] 
(2012) 
4 
Potentiometric sensing using polycation 
sensitive membrane electrode 
S1 nuclease 
DNase I 
0.32 unit/mL 
0.45 unit/mL 
- 
1–10 unit/mL 
[25] 
(2013) 
5 
ds DNA template formation Cu 
nanoparticle 
S1 nuclease 0.3 unit/mL 1–50 unit/mL 
[26] 
(2013) 
6 
Positively charged QDs-based  
FRET probe 
MNase 1.6 unit/L 8–90 unit/L 
[27] 
(2013) 
7 
Electrochemical detection using  
FcODN modified electrode  
(cytosine oligonucleotide) 
RNase A 10 pg/mL 1 pg/mL–1 μg/mL 
[31] 
(2013) 
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